Brought to you by 
Series B brings in $43.6mm for SARcode Bioscience
19 Aug 2011
Executive Summary
SARcode Bioscience Inc. (ophthalmic and dermatology therapeutics) has raised $43.6mm through its Series B venture round. Sofinnova Ventures led and was joined by fellow new backer Rho Ventures and current shareholders Alta Partners and Clarus Ventures, as well as five other undisclosed investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B brings in $43.6mm for SARcode Bioscience
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice